Published in Proc Natl Acad Sci U S A on June 01, 1993
Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol (1995) 2.80
Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Mol Cell Biol (1994) 2.59
Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol (1995) 2.36
In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci U S A (1999) 2.17
Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol (1994) 2.16
Activation of signalling by the activin receptor complex. Mol Cell Biol (1996) 1.79
The types II and III transforming growth factor-beta receptors form homo-oligomers. J Cell Biol (1994) 1.76
Complementation between kinase-defective and activation-defective TGF-beta receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J (1996) 1.61
Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane. J Cell Biol (1998) 1.56
Retracted TGFbeta1 signaling via alphaVbeta6 integrin. Mol Cancer (2003) 1.47
CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis. Hepatology (2009) 1.40
Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases. Proc Natl Acad Sci U S A (1995) 1.40
Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex. Mol Cell Biol (1994) 1.32
Reconstitution and transphosphorylation of TGF-beta receptor complexes. EMBO J (1994) 1.30
The latent transforming growth factor beta binding protein (LTBP) family. Biochem J (2000) 1.27
Positive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues. EMBO J (1997) 1.26
Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor. Proc Natl Acad Sci U S A (1993) 1.19
A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol (1996) 1.09
Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines. Br J Cancer (1999) 1.08
Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann Surg (1995) 1.00
Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption. Am J Pathol (1999) 0.96
Role of Radiation-induced TGF-beta Signaling in Cancer Therapy. Mol Cell Pharmacol (2009) 0.95
Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line. Proc Natl Acad Sci U S A (1994) 0.92
Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (1997) 0.92
The transforming growth factor beta type II receptor can replace the activin type II receptor in inducing mesoderm. Mol Cell Biol (1994) 0.90
Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor. Br J Cancer (1994) 0.88
Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-beta complex from the cell surface. Biochem J (1994) 0.87
Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism. J Exp Med (2002) 0.85
Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors. J Biol Chem (2009) 0.83
Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo. World J Gastroenterol (2005) 0.82
TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells. PLoS One (2013) 0.82
Leucine-rich α-2-glycoprotein promotes TGFβ1-mediated growth suppression in the Lewis lung carcinoma cell lines. Oncotarget (2015) 0.81
Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines. Br J Cancer (1996) 0.80
Inhibition of spermidine synthase gene expression by transforming growth factor-beta 1 in hepatoma cells. Biochem J (1997) 0.78
Acquired genetic and functional alterations associated with transforming growth factor beta type I resistance in Hep3B human hepatocellular carcinoma cell line. J Cell Mol Med (2009) 0.78
Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies. Biochem J (1996) 0.75
Co-administration of cyclosporine an alleviates thioacetamide-induced liver injury. World J Gastroenterol (2005) 0.75
Ultraviolet irradiation represses TGF-β type II receptor transcription through a 38-bp sequence in the proximal promoter in human skin fibroblasts. Exp Dermatol (2014) 0.75
The transforming growth factor-beta family. Annu Rev Cell Biol (1990) 10.62
TGF beta signals through a heteromeric protein kinase receptor complex. Cell (1992) 8.12
A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci U S A (1987) 6.36
Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell (1992) 4.68
TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell (1990) 4.28
Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J Biol Chem (1984) 4.20
The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell (1987) 3.52
Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets. Proc Natl Acad Sci U S A (1984) 3.01
Receptors for the TGF-beta family. Cell (1992) 3.00
Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J Biol Chem (1989) 2.29
Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. J Biol Chem (1990) 2.24
Two forms of transforming growth factor-beta distinguished by multipotential haematopoietic progenitor cells. Nature (1987) 2.13
Cellular distribution of type I and type II receptors for transforming growth factor-beta. J Biol Chem (1986) 1.82
Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells. Science (1988) 1.72
Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II. J Biol Chem (1991) 1.71
Inhibition of growth by transforming growth factor-beta following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses. J Biol Chem (1992) 1.52
Receptors for the TGF-beta superfamily: multiple polypeptides and serine/threonine kinases. Trends Cell Biol (1993) 1.52
TGF-beta receptors and TGF-beta binding proteoglycans: recent progress in identifying their functional properties. Ann N Y Acad Sci (1990) 1.49
The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor. J Biol Chem (1988) 1.47
The high molecular weight receptor to transforming growth factor-beta contains glycosaminoglycan chains. J Biol Chem (1988) 1.44
Binding of transforming growth factor-beta to cell surface proteins varies with cell type. Mol Endocrinol (1989) 1.27
Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. Exp Cell Res (1989) 1.21
Structure and properties of the cellular receptor for transforming growth factor type beta. Biochemistry (1986) 1.19
TGF-beta in liver development, regeneration, and carcinogenesis. Ann N Y Acad Sci (1990) 0.93
Cell type specificity of TGF-beta binding. Ann N Y Acad Sci (1990) 0.91
Transforming growth factor-beta (TGF-beta)-resistant helper T lymphocyte clones show a concomitant loss of all three types of TGF-beta receptors. J Immunol (1991) 0.87
Transforming growth factor beta (TGF-beta) type V receptor has a TGF-beta-stimulated serine/threonine-specific autophosphorylation activity. J Biol Chem (1992) 0.85
Role of transforming growth factor beta in human disease. N Engl J Med (2000) 10.17
A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem (1995) 9.72
pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci U S A (1983) 8.41
Sequence and structure of a human glucose transporter. Science (1985) 8.03
Synchronised transmembrane insertion and glycosylation of a nascent membrane protein. Nature (1977) 7.72
Multiple mechanisms of protein insertion into and across membranes. Science (1985) 7.70
Oxidized redox state of glutathione in the endoplasmic reticulum. Science (1992) 6.91
Intracellular site of asialoglycoprotein receptor-ligand uncoupling: double-label immunoelectron microscopy during receptor-mediated endocytosis. Cell (1983) 6.89
Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood (2001) 6.35
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A (2001) 6.20
Membrane assembly in vitro: synthesis, glycosylation, and asymmetric insertion of a transmembrane protein. Proc Natl Acad Sci U S A (1977) 5.51
Oligomerization is essential for transport of vesicular stomatitis viral glycoprotein to the cell surface. Cell (1986) 5.19
Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells. Cell (1988) 5.18
Predicting the orientation of eukaryotic membrane-spanning proteins. Proc Natl Acad Sci U S A (1989) 5.15
Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell (1995) 4.73
Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell (1999) 4.69
Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell (1992) 4.68
Expression cloning of the murine erythropoietin receptor. Cell (1989) 4.59
Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature (1990) 4.59
Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents. J Biol Chem (1983) 4.55
A signal sequence for the insertion of a transmembrane glycoprotein. Similarities to the signals of secretory proteins in primary structure and function. J Biol Chem (1978) 4.43
Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell (1994) 4.33
Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell (1995) 4.32
Intracellular transport of secretory and membrane proteins in hepatoma cells infected by vesicular stomatitis virus. Cell (1980) 4.15
Hepatoma secretory proteins migrate from rough endoplasmic reticulum to Golgi at characteristic rates. Nature (1983) 4.12
Separate pathways of maturation of the major structural proteins of vesicular stomatitis virus. J Virol (1977) 4.03
Initiation of haemoglobin synthesis by methionyl-tRNA. Nature (1970) 3.99
Translational control of protein synthesis. Annu Rev Biochem (1976) 3.66
Mutants of vesicular stomatitis virus blocked at different stages in maturation of the viral glycoprotein. Cell (1980) 3.65
Translation of reovirus mRNA, poliovirus RNA and bacteriophage Qbeta RNA in cell-free extracts of mammalian cells. Methods Enzymol (1974) 3.60
Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science (1987) 3.44
TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci (1999) 3.43
Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol (2000) 3.42
Model for the regulation of mRNA translation applied to haemoglobin synthesis. Nature (1974) 3.37
Maturation of viral proteins in cells infected with temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1977) 3.30
Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem (1994) 3.29
Alpha and beta globin messenger ribonucleic acid. Different amounts and rates of initiation of translation. J Biol Chem (1971) 3.24
Developmental regulation of Dictyostelium discoideum actin gene fusions carried on low-copy and high-copy transformation vectors. Mol Cell Biol (1986) 3.20
Localization of two cellular forms of the vesicular stomatitis viral glycoprotein. J Virol (1977) 3.20
Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J Biol Chem (1997) 3.14
Translation of individual species of vesicular stomatitis viral mRNA. J Virol (1975) 3.12
Translation of vesicular stomatitis messenger RNA by extracts from mammalian and plant cells. J Virol (1974) 3.06
Linkage of faulty major histocompatibility complex class I to autoimmune diabetes. Science (1991) 2.99
A glucose transport protein expressed predominately in insulin-responsive tissues. Proc Natl Acad Sci U S A (1989) 2.98
Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci U S A (1997) 2.97
Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem (1996) 2.95
Biosynthesis of HLA-A and HLA-B antigens in vivo. J Biol Chem (1980) 2.94
Translation of murine leukemia virus RNA in cell-free systems from animal cells. J Virol (1976) 2.94
Expression cloning and characterization of the TGF-beta type III receptor. Cell (1991) 2.89
Secondary structure of bacteriophage f2 ribonucleic acid and the initiation of in vitro protein biosynthesis. J Mol Biol (1970) 2.89
Bacteriophage f2 RNA: control of translation and gene order. Nature (1968) 2.87
Translation in vitro of vesicular stomatitis virus mRNA lacking 5'-terminal 7-methylguanosine. Nature (1976) 2.81
The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol Cell Biol (1991) 2.77
An internal signal sequence: the asialoglycoprotein receptor membrane anchor. Cell (1986) 2.74
Translation of reovirus messenger RNAs synthetesized in vitro into reovirus polypeptides by several mammalian cell-free extracts. Proc Natl Acad Sci U S A (1972) 2.69
Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J Cell Biol (1994) 2.69
Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci U S A (1996) 2.68
Identification of the major intestinal fatty acid transport protein. Mol Cell (1999) 2.65
Primary structure and transmembrane orientation of the murine anion exchange protein. Nature (1985) 2.61
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology (1997) 2.57
Specificity in bacterial protein synthesis: role of initiation factors and ribosomal subunits. Nature (1970) 2.57
Developmental changes in messenger RNAs and protein synthesis in Dictyostelium discoideum. Dev Biol (1977) 2.55
The human glucose transporter can insert posttranslationally into microsomes. Cell (1986) 2.53
Analysis of the defects of temperature-sensitive mutants of vesicular stomatitis virus: intracellular degradation of specific viral proteins. J Virol (1977) 2.52
Replication of the RNA of Bacteriophage f2. Science (1966) 2.48
Synthesis and stability of developmentally regulated dictyostelium mRNAs are affected by cell--cell contact and cAMP. Cell (1981) 2.47
Regulation of dictyostelium discoideum mRNAs specific for prespore or prestalk cells. Cell (1983) 2.45
The sucrase-isomaltase complex: primary structure, membrane-orientation, and evolution of a stalked, intrinsic brush border protein. Cell (1986) 2.43
Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line. J Biol Chem (1982) 2.35
Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature (1990) 2.33
Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J Biol Chem (2000) 2.31
Homodimerization and constitutive activation of the erythropoietin receptor. Proc Natl Acad Sci U S A (1992) 2.29
Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev (1998) 2.29
Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J Biol Chem (1995) 2.25
Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. Proc Natl Acad Sci U S A (1990) 2.23
TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol (2001) 2.22
Sequence of a second human asialoglycoprotein receptor: conservation of two receptor genes during evolution. Proc Natl Acad Sci U S A (1985) 2.22
How a single Sindbis virus mRNA directs the synthesis of one soluble protein and two integral membrane glycoproteins. Cell (1977) 2.19
Erythropoietin receptor and interleukin-2 receptor beta chain: a new receptor family. Cell (1989) 2.13
Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene (2007) 2.12
A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci U S A (1998) 2.12
Glycosylation of a membrane protein is restricted to the growing polypeptide chain but is not necessary for insertion as a transmembrane protein. Cell (1978) 2.11
The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol Cell (2001) 2.10
Activation of the erythropoietin receptor promoter by transcription factor GATA-1. Proc Natl Acad Sci U S A (1991) 2.10
The asialoglycoprotein receptor internalizes and recycles independently of the transferrin and insulin receptors. Cell (1983) 2.10
SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc Natl Acad Sci U S A (1999) 2.06
Localization of the pancreatic beta cell glucose transporter to specific plasma membrane domains. Science (1989) 2.04
Characterization of the asialoglycoprotein receptor in a continuous hepatoma line. J Biol Chem (1981) 2.04
A simple and inexpensive procedure for preparative polyacrylamide gel electrophoresis of RNA. Anal Biochem (1973) 2.04
Liver glucose transporter: a basolateral protein in hepatocytes and intestine and kidney cells. Am J Physiol (1990) 2.03
A small nuclear precursor of messenger RNA in the cellular slime mold Dictyostelium discoideum. J Mol Biol (1973) 2.01
Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc Natl Acad Sci U S A (2001) 2.00
Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor. Cancer Res (1986) 1.97
Glucose removal from N-linked oligosaccharides is required for efficient maturation of certain secretory glycoproteins from the rough endoplasmic reticulum to the Golgi complex. J Cell Biol (1984) 1.97
Vesicular stomatitis virus glycoprotein, albumin, and transferrin are transported to the cell surface via the same Golgi vesicles. J Cell Biol (1983) 1.94
Initiation sites for translation of sindbis virus 42S and 26S messenger RNAs. Cell (1975) 1.94
Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. Proc Natl Acad Sci U S A (1991) 1.93
Tankyrase is a golgi-associated mitogen-activated protein kinase substrate that interacts with IRAP in GLUT4 vesicles. J Biol Chem (2000) 1.93
Distribution of glucose transporter messenger RNA transcripts in tissues of rat and man. J Clin Invest (1987) 1.93